Skip to content

Effectiveness of oral midodrine drug in reducing vasopressor dependence among ICU patients with septic shock:A prospective Randomized Trial.

Impact of oral midodrine to liberate Icu patients from vasopressor infusion in septic shock:Aprospective Randomised control trial - NIL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/11/059796
Enrollment
110
Registered
2023-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: R652- Severe sepsis

Interventions

Intervention1: Adding oral midodrine to intervention group: Adding Oral or through Ryles tube of midodrine tablet of 10 mg QID to intervention group till patient is become off from inotrope support

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Septic shock patients on dual vasopressor support

Exclusion criteria

Exclusion criteria: CKD PREGNANCY PRE-EXISTING LOVER DISEASE BRADYCARDIA of Severe organic heart disease Known allergy to midodrine

Design outcomes

Primary

MeasureTime frame
Time is taken to de-escalate to a single low-dose vasopressor (defined as noradrenaline =0.15 µg/kg/min) after administration of oral midodrine or placebo.Timepoint: During the course of icu stay

Secondary

MeasureTime frame
1.Vasoactive inotropic score (VIS) score trend, recorded 6th hourly till the patient is off inotropic support. Timepoint: During the icu stay;2. Maximum VIS score during ICU stay. Timepoint: During the icy stay;3. Mean VIS during ICU stay. Timepoint: During icu stay;4. Time taken for complete weaning off from inotropic support (in hours). Timepoint: During the Icu stay;5. Length of ICU stay. Timepoint: During the Icu stay;6. Mortality during ICU stay,Timepoint: During the Icu stay

Countries

India

Contacts

Public ContactDr ANAS V P

PGIMER CHANDIGARH

drvsaini@gmail.com7087008119

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026